GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Visgeneer Inc (ROCO:4197) » Definitions » Research & Development

Visgeneer (ROCO:4197) Research & Development : NT$25.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Visgeneer Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Visgeneer's Research & Development for the six months ended in Dec. 2023 was NT$13.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was NT$25.4 Mil.

Visgeneer Research & Development Historical Data

The historical data trend for Visgeneer's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visgeneer Research & Development Chart

Visgeneer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.35 23.15 26.05 25.37 25.42

Visgeneer Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.91 12.95 12.41 12.40 13.02

Visgeneer Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$25.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Visgeneer  (ROCO:4197) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Visgeneer Research & Development Related Terms

Thank you for viewing the detailed overview of Visgeneer's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Visgeneer (ROCO:4197) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Visgeneer Inc (ROCO:4197) » Definitions » Research & Development
Comparable Companies
ROCO:6744 ROCO:6848 ROCO:6864 ROCO:6662 ROCO:4131 ROCO:3118 ROCO:6917 ROCO:6814 ROCO:6549 ROCO:6808 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Number 335, Sec. 6, Zhonghua Road, Xiangshan District, Hsinchu, TWN, 30094
Website
http://www.visgeneer.com.tw
Visgeneer Inc is a Taiwan based Biotech company involved in developing and, manufacturing biomedical products in the areas of Bacterial Fermentation, Medical Device, Cosmetics/Skin Care, and Cancer Gene identification. Its products include Blood Glucose and Ketone Monitoring System, Ginkgo Biloba series, Peptide-Complex series, Hyaluronic Acid Essence Series and High-Quality Masks among others.

Visgeneer (ROCO:4197) Headlines

No Headlines